Jin Medical International Ltd. (ZJYL)

NASDAQ: ZJYL · Real-Time Price · USD

1.940

-0.110 (-5.36%)

At close: Oct 26, 2026, 4:00 PM EDT

1.960

+0.020 (1.03%)

After-hours: Oct 26, 2026, 5:31 PM EDT

Jin Medical International Financials Overview

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	19.73	20.69	23.5	19.82	19.19	20.76
Revenue Growth	-4.65%	-11.98%	18.57%	3.29%	-7.58%	28.22%
Gross Profit	6.17	6.24	9.61	6.96	6.36	6.59
Operating Income	0.42	0.61	3.64	2.87	2.13	2.63
Net Income	1.17	1.19	3.68	2.88	2.71	2.63
Earnings Per Share	0.15	0.15	0.47	0.40	0.40	0.39
EPS Growth	-1.57%	-67.61%	18.46%	-1.08%	2.84%	253.48%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Mainland China	3.74	4.41	8.61	2.74	2.74	2.55
Japan	-	12.13	11.2	13.84	14	16.37
U.S.	-	1.66	1.63	1.44	0.85	0.69
Hong Kong	-	0.44	0.55	0.04	0.5	0.47
Singapore	-	0.2	0.18	0.95	0.13	0.1
Korean	-	1.34	0.85	0.62	0.65	0.02
Australia	-	0.2	0.22	-	0.18	0.28
Others	-	0.3	0.27	0.19	0.14	0.29
Total	19.73	20.69	23.5	19.82	19.19	20.76

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Investments	30.1	29.63	26.76	16.7	7.07	5.73
Total Debt	20.9	18.91	11.6	4.11	-	-
Net Cash (Debt)	9.2	10.72	15.15	12.59	7.07	5.73
Net Cash Growth	-14.18%	-29.26%	20.41%	78.04%	23.43%	2879.90%
Net Cash Per Share	1.18	1.37	1.94	1.73	1.05	0.85

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Operating Cash Flow	-0.59	2.9	-1.21	3.11	1.58	5.84
Capital Expenditures	-6.37	-6.63	-0.14	-0.11	-0.04	-0.04
Free Cash Flow	-6.96	-3.73	-1.35	2.99	1.54	5.8
Free Cash Flow Growth	-	-	-	94.25%	-73.44%	145.69%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Gross Margin	31.28%	30.18%	40.89%	35.14%	33.13%	31.72%
Operating Margin	2.12%	2.94%	15.48%	14.46%	11.10%	12.67%
Pretax Margin	6.40%	7.71%	17.80%	16.25%	14.29%	13.87%
Profit Margin	5.95%	5.76%	15.64%	14.52%	14.10%	12.67%
FCF Margin	-35.28%	-18.01%	-5.75%	15.10%	8.03%	27.93%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 26, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
PE Ratio	12.95	74.25	114.56	63.39	-	-
P/FCF Ratio	-	-	-	60.97	-	-
PS Ratio	7.95	4.28	17.92	9.21	-	-